Konica Minolta has agreed to acquire Ambry Genetics for up to $1 billion, the companies said on July 5, 2017, in a deal the buyer envisions as the first step in its strategy of developing a ...

New study published in Genetics in Medicine reveals transformative impact of Ambry's Patient for Life reanalysis program.

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics defeated an appeal by Myriad Genetics to block competing DNA-based tests to determine hereditary risk for breast and ovarian cancer after a ...

A subsidiary of Japanese office equipment manufacturer Konica Minolta Inc. will acquire Aliso Viejo-based genetic testing firm Ambry Genetics Corp. in a deal valued at up to $1 billion ...

Aliso Viejo-based Ambry Genetics Corp. on Nov. 4 announced an agreement to be acquired for $600 million by Tempus AI Inc. “They’ve achieved one of the rare things in our space where you actually have ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a leader in clinical diagnostic testing and a subsidiary of REALM IDx, Inc., announced today the findings of a study that showed paired RNA ...

Shares of Tempus AI TEM gained 18.4% after it announced an agreement, on Nov. 4, 2024, to acquire Ambry Genetics for $600 ...

Tempus AI delivered strong Q1 results, driven by the Ambry Genetics acquisition and a major AstraZeneca contract, boosting ...

Just weeks after it lost at the high court, Myriad filed new lawsuits against the first two competitors who began offering BRCA gene testing, Ambry Genetics and Gene by Gene. Despite its Supreme ...

ALISO VIEJO – Charles Dunlop, founder and CEO of Ambry Genetics, never tested his own DNA even though he had the technology at his fingertips. He refused to displace a vial of a patient’s ...

Ambry Genetics has already identified 10-fold more genes implicated in these conditions than previously known to the public, broadening understanding and potentially opening up more drug targets than ...